دورية أكاديمية
أعرض في EDS

High final energy of gallium arsenide laser increases MyoD gene expression during the intermediate phase of muscle regeneration after cryoinjury in rats.

التفاصيل البيبلوغرافية
العنوان: High final energy of gallium arsenide laser increases MyoD gene expression during the intermediate phase of muscle regeneration after cryoinjury in rats.
المؤلفون: Santos CP; Department of Physical Therapy, University of Western São Paulo (UNOESTE), Presidente Prudente, São Paulo, Brazil., Aguiar AF; Center of Research in Health Science, North University of Paraná (UNOPAR), Avenue Paris, 675, Jardim Piza, Londrina, PR, 86041-120, Brazil. afaguiarunesp@gmail.com., Giometti IC; Department of Physical Therapy, University of Western São Paulo (UNOESTE), Presidente Prudente, São Paulo, Brazil., Mariano TB; Department of Physical Therapy, University of Western São Paulo (UNOESTE), Presidente Prudente, São Paulo, Brazil., de Freitas CEA; Department of Physical Therapy, University of Western São Paulo (UNOESTE), Presidente Prudente, São Paulo, Brazil., Nai GA; Department of Physical Therapy, University of Western São Paulo (UNOESTE), Presidente Prudente, São Paulo, Brazil., de Freitas SZ; Department of Physical Therapy, University of Western São Paulo (UNOESTE), Presidente Prudente, São Paulo, Brazil., Pai-Silva MD; Department of Morphology, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil., Pacagnelli FL; Department of Physical Therapy, University of Western São Paulo (UNOESTE), Presidente Prudente, São Paulo, Brazil.
المصدر: Lasers in medical science [Lasers Med Sci] 2018 May; Vol. 33 (4), pp. 843-850. Date of Electronic Publication: 2018 Jan 15.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer Country of Publication: England NLM ID: 8611515 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-604X (Electronic) Linking ISSN: 02688921 NLM ISO Abbreviation: Lasers Med Sci Subsets: MEDLINE
أسماء مطبوعة: Publication: London : Springer
Original Publication: London : Baillière Tindall, c1986-
مواضيع طبية MeSH: Low-Level Light Therapy*, Athletic Injuries/*radiotherapy , Lasers, Semiconductor/*therapeutic use , Muscle, Skeletal/*injuries , MyoD Protein/*genetics, Animals ; Cold Temperature ; Collagen/genetics ; Collagen/metabolism ; Gene Expression/radiation effects ; Insulin-Like Growth Factor I/genetics ; Insulin-Like Growth Factor I/metabolism ; Male ; Muscle, Skeletal/metabolism ; Muscle, Skeletal/radiation effects ; MyoD Protein/metabolism ; Rats ; Rats, Wistar ; Tumor Necrosis Factor-alpha/genetics ; Tumor Necrosis Factor-alpha/metabolism
مستخلص: The aim of this study was to determine the effects of gallium arsenide (GaAs) laser on IGF-I, MyoD, MAFbx, and TNF-α gene expression during the intermediate phase of muscle regeneration after cryoinjury 21 Wistar rats were divided into three groups (n = 7 per group): untreated with no injury (control group), cryoinjury without GaAs (injured group), and cryoinjury with GaAs (GaAs-injured group). The cryoinjury was induced in the central region of the tibialis anterior muscle (TA). The region injured was irradiated once a day during 14 days using GaAs laser (904 nm; spot size 0.035 cm 2 , output power 50 mW; energy density 69 J cm -2 ; exposure time 4 s per point; final energy 4.8 J). Twenty-four hours after the last application, the right and left TA muscles were collected for histological (collagen content) and molecular (gene expression of IGF-I, MyoD, MAFbx, and TNF-α) analyses, respectively. Data were analyzed using one-way ANOVA at P < 0.05. There were no significant (P > 0.05) differences in collagen density and IGF-I gene expression in all experimental groups. There were similar (P < 0.05) decreases in MAFbx and TNF-α gene expression in the injured and GaAs-injured groups, compared to control group. The MyoD gene expression increased (P = 0.008) in the GaAs-injured group, but not in the injured group (P = 0.338), compared to control group. GaAs laser therapy had a positive effect on MyoD gene expression, but not IGF-I, MAFbx, and TNF-α, during intermediary phases (14 days post-injury) of muscle repair.
References: Lasers Med Sci. 2013 May;28(3):947-55. (PMID: 22898787)
Acta Cir Bras. 2012 Oct;27(10):681-6. (PMID: 23033128)
J Physiol. 2003 Jun 1;549(Pt 2):409-18. (PMID: 12692175)
Am J Sports Med. 2011 Jun;39(6):1226-32. (PMID: 21335353)
J Photochem Photobiol B. 2013 Mar 5;120:29-35. (PMID: 23416710)
Photochem Photobiol. 2015 Jul-Aug;91(4):957-65. (PMID: 25752215)
Lasers Med Sci. 2016 May;31(4):679-85. (PMID: 26914683)
Lasers Surg Med. 1999;25(1):13-21. (PMID: 10421882)
Eur J Cell Biol. 1997 Dec;74(4):391-8. (PMID: 9438136)
Photomed Laser Surg. 2011 Jan;29(1):11-7. (PMID: 20701543)
In Vivo. 2009 Sep-Oct;23(5):779-96. (PMID: 19779115)
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034. (PMID: 12184808)
Am J Sports Med. 2005 May;33(5):745-64. (PMID: 15851777)
Cell Mol Life Sci. 2013 Nov;70(21):4117-30. (PMID: 23552962)
Methods. 2001 Dec;25(4):402-8. (PMID: 11846609)
Lasers Med Sci. 2012 Sep;27(5):993-1000. (PMID: 22143119)
Lasers Med Sci. 2013 Feb;28(2):431-6. (PMID: 22399243)
J Photochem Photobiol B. 2017 Feb;167:256-263. (PMID: 28088107)
J Photochem Photobiol B. 2017 Mar;168:30-39. (PMID: 28161653)
J Appl Physiol (1985). 2005 May;98(5):1745-52. (PMID: 15618316)
J Appl Physiol (1985). 2007 Nov;103(5):1744-51. (PMID: 17823296)
Physiol Rev. 2004 Jan;84(1):209-38. (PMID: 14715915)
Br J Sports Med. 2013 Apr;47(6):351-8. (PMID: 22763118)
Photomed Laser Surg. 2010 Feb;28(1):17-21. (PMID: 19764898)
Lasers Med Sci. 2014 Mar;29(2):813-21. (PMID: 23982721)
Muscle Nerve. 2008 Oct;38(4):1246-53. (PMID: 18785187)
Acta Orthop. 2011 Feb;82(1):102-11. (PMID: 21142822)
Lasers Med Sci. 2011 May;26(3):335-40. (PMID: 21053039)
J Biol Chem. 2000 Nov 24;275(47):36750-7. (PMID: 10973962)
Lasers Surg Med. 2006 Aug;38(7):704-13. (PMID: 16799998)
FASEB J. 2007 May;21(7):1393-402. (PMID: 17264161)
Am J Phys Med Rehabil. 2014 Dec;93(12):1073-85. (PMID: 25122099)
Photomed Laser Surg. 2006 Dec;24(6):761-2. (PMID: 17199479)
FASEB J. 2004 Feb;18(2):227-37. (PMID: 14769817)
FASEB J. 1998 Jul;12(10):871-80. (PMID: 9657527)
Br J Sports Med. 2012 Jun;46(7):505-14. (PMID: 22522588)
J Biol Chem. 2005 Jan 28;280(4):2847-56. (PMID: 15531760)
Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1206-10. (PMID: 14745025)
Physiol Genomics. 2002 Dec 3;11(3):263-72. (PMID: 12399448)
Lasers Med Sci. 2013 May;28(3):735-42. (PMID: 22714675)
J Cell Physiol. 2010 Jul;224(1):7-16. (PMID: 20232319)
Lasers Surg Med. 2012 Nov;44(9):726-35. (PMID: 23001637)
Lasers Med Sci. 1998 Dec;13(4):293-8. (PMID: 24710991)
Lasers Surg Med. 2008 Jan;40(1):38-45. (PMID: 18220266)
Lasers Surg Med. 2007 Apr;39(4):365-72. (PMID: 17457843)
معلومات مُعتمدة: 146045/2013-0 Conselho Nacional de Desenvolvimento Científico e Tecnológico
فهرسة مساهمة: Keywords: Gallium arsenide laser; IGF-I; MAFbx; Muscle regeneration; MyoD; TNF-α gene expression
المشرفين على المادة: 0 (MyoD Protein)
0 (Tumor Necrosis Factor-alpha)
67763-96-6 (Insulin-Like Growth Factor I)
9007-34-5 (Collagen)
تواريخ الأحداث: Date Created: 20180116 Date Completed: 20180615 Latest Revision: 20181202
رمز التحديث: 20221213
DOI: 10.1007/s10103-018-2439-3
PMID: 29333581
قاعدة البيانات: MEDLINE
الوصف
تدمد:1435-604X
DOI:10.1007/s10103-018-2439-3